Aprea Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APRE and other ETFs, options, and stocks.

About APRE

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. 

CEO
Oren Gilad
CEOOren Gilad
Employees
8
Employees8
Headquarters
Doylestown, Pennsylvania
HeadquartersDoylestown, Pennsylvania
Founded
2002
Founded2002
Employees
8
Employees8

APRE Key Statistics

Market cap
4.10M
Market cap4.10M
Price-Earnings ratio
-0.28
Price-Earnings ratio-0.28
Dividend yield
Dividend yield
Average volume
11.54M
Average volume11.54M
High today
$0.6439
High today$0.6439
Low today
$0.58
Low today$0.58
Open price
$0.5868
Open price$0.5868
Volume
17.49K
Volume17.49K
52 Week high
$3.72
52 Week high$3.72
52 Week low
$0.548
52 Week low$0.548

Stock Snapshot

As of today, Aprea Therapeutics(APRE) shares are valued at $0.59. The company's market cap stands at 4.1M, with a P/E ratio of -0.28.

As of 2026-02-13, Aprea Therapeutics(APRE) stock has fluctuated between $0.58 and $0.64. The current price stands at $0.59, placing the stock +1.0% above today's low and -9.0% off the high.

The Aprea Therapeutics(APRE)'s current trading volume is 17.49K, compared to an average daily volume of 11.54M.

During the past year, Aprea Therapeutics(APRE) stock moved between $0.55 at its lowest and $3.72 at its peak.

During the past year, Aprea Therapeutics(APRE) stock moved between $0.55 at its lowest and $3.72 at its peak.

People also own

Based on the portfolios of people who own APRE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.